Aubuchon Neil William — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Aubuchon Neil William is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $150K.
Profile
Neil William Aubuchon is a corporate insider serving as Chief Commercial Officer of Viking Therapeutics, Inc., as disclosed in an SEC filing dated 2026-01-27 (CIK 0002106781). Viking Therapeutics is described as a healthcare service provider focused on biopharmaceutical development for metabolic and endocrine disorders, with a pipeline including VK2809, VK5211, and VK0214. The filing shows no stock purchases or sales for this individual in that report.
Role
Insider
Notability
42/100
Board memberships
Viking Therapeutics, Inc.
Awards & honors
Appointed Chief Commercial Officer at Viking Therapeutics
Overseeing commercial strategy for VKTX's metabolic/endocrine product pipeline
Neil William Aubuchon is a corporate insider serving as Chief Commercial Officer of Viking Therapeutics, Inc., as disclosed in an SEC filing dated 2026-01-27 (CIK 0002106781). Viking Therapeutics is described as a healthcare service provider focused on biopharmaceutical development for metabolic and endocrine disorders, with a pipeline including VK2809, VK5211, and VK0214. The …
Has Aubuchon Neil William been buying or selling stock?
Recorded transactions: 1 open-market purchases ($150K) and 0 open-market sales () across all tracked filings.
Where can I see all of Aubuchon Neil William's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
